CD2AP and neoplasm: We further explored the correlations between CD2AP mRNA levels and clinical features (age, gender, tumour stage, and TNM stages), and the results showed that, compared to the T1 stage, CD2AP levels were significantly higher in the advanced stages (T2-T4) (Supplementary Figure S3).